Wai Chun Bio-Technology Limited (HKG:0660)

Revenue by Segment

Financials in millions HKD. Fiscal year is July - June.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Modified Starch and Other Biochemical Products	377.17M	370.07M	773.65M	671.46M	495.38M
Modified Starch and Other Biochemical Products Growth	1.92%	-52.17%	15.22%	35.54%	-12.72%
Total	377.17M	370.07M	773.65M	671.46M	495.38M
Total Growth	1.92%	-52.17%	15.22%	35.54%	-12.72%

Revenue by Geography

Financials in millions HKD. Fiscal year is July - June.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
The PRC (excluding Hong Kong)	377.17M	370.07M	773.65M	671.46M	495.38M
The PRC (excluding Hong Kong) Growth	1.92%	-52.17%	15.22%	35.54%	-12.72%
Total	377.17M	370.07M	773.65M	671.46M	495.38M
Total Growth	1.92%	-52.17%	15.22%	35.54%	-12.72%

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2025

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Jul 17, 2026

Data Sources Report a data error